Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 1990 Oct;82(1):174-80.
doi: 10.1111/j.1365-2249.1990.tb05423.x.

CD8+/DR+ T gamma cells inhibit the autologous mixed lymphocyte reaction

Affiliations

CD8+/DR+ T gamma cells inhibit the autologous mixed lymphocyte reaction

M K Haynes et al. Clin Exp Immunol. 1990 Oct.

Abstract

The proliferative response of T cells during autologous mixed lymphocyte reactions (AMLR) was affected by depletion of IgG Fc receptor+ T lymphocytes (Tg). Removal of Tg cells resulted in enhanced proliferation, and EA-rosette isolated Tg cells, when added to AMLR cultures as irradiated third components, reduced the uptake of 3H-thymidine by 63-87% in a dose-dependent manner. Negative selection using an avidin-biotin affinity chromatography technique demonstrated that the suppression was mediated by DR+ Tg cells; the major proportion of which also expressed the CD8 antigen. By comparing AMLR supernatants collected from control (lacking Tg) and suppressed (containing Tg) cultures on days 2, 3, and 4, it was established that supernatants from suppressed cultures had significantly reduced levels of cytokine activity. These data indicate that the CD8+/DR+ Tg cells function as suppressor cells during an AMLR and reduce the proliferative response by inhibiting AMLR responder T cells from producing the cytokines necessary for in vitro growth.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Immunol Rev. 1983;74:5-28 - PubMed
    1. Transplantation. 1983 Nov;36(5):495-501 - PubMed
    1. Clin Exp Immunol. 1984 May;56(2):390-8 - PubMed
    1. J Clin Immunol. 1985 May;5(3):187-94 - PubMed
    1. J Exp Med. 1986 Nov 1;164(5):1682-99 - PubMed

Publication types